The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical outcomes of first-line FOLFIRINOX versus gemcitabine plus nab-paclitaxel in metastatic pancreatic cancer at the Yale Smilow Healthcare System.
 
Timil Patel
No Relationships to Disclose
 
Thejal Srikumar
No Relationships to Disclose
 
Joseph Anthony Miccio
No Relationships to Disclose
 
Jill Lacy
Consulting or Advisory Role - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Celgene; Celgene; Celgene; Celgene; KeyQuest Health; KeyQuest Health; KeyQuest Health; KeyQuest Health; Merck; Merck; Merck; Merck; Navigant Consulting; Navigant Consulting; Navigant Consulting; Navigant Consulting; Sirtex Medical; Sirtex Medical; Sirtex Medical; Sirtex Medical
Travel, Accommodations, Expenses - Lilly; Lilly; Lilly; Lilly
 
Stacey Stein
Consulting or Advisory Role - Eisai; Eisai; Eisai; Eisai; Genentech/Roche; Genentech/Roche; Genentech/Roche; Genentech/Roche; Merck; Merck; Merck; Merck
 
Jeremy S. Kortmansky
No Relationships to Disclose
 
Carol Staugaard
No Relationships to Disclose
 
Melissa Gambaccini
No Relationships to Disclose
 
Alfredo Axtmayer
No Relationships to Disclose
 
Michael Cecchini
Honoraria - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Eisai; Eisai; Eisai; Eisai
Travel, Accommodations, Expenses - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Eisai; Eisai; Eisai; Eisai